0
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      The impact of outdoor pollution and extreme temperatures on asthma‐related outcomes: A systematic review for the EAACI guidelines on environmental science for allergic diseases and asthma

      1 , 2 , 3 , 4 , 2 , 2 , 2 , 2 , 2 , 5 , 2 , 5 , 2 , 5 , 6 , 7 , 8 , 9 , 10 , 11 , 11 , 12 , 13 , 14 , 15 , 16 , 17 , 18 , 19 , 20 , 11 , 21 , 22 , 23 , 24 , 25 , 26 , 2 , 5 , 2 , 27 , 28
      Allergy
      Wiley

      Read this article at

      ScienceOpenPublisher
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Air pollution is one of the biggest environmental threats for asthma. Its impact is augmented by climate change. To inform the recommendations of the EAACI Guidelines on the environmental science for allergic diseases and asthma, a systematic review (SR) evaluated the impact on asthma‐related outcomes of short‐term exposure to outdoor air pollutants (PM2.5, PM10, NO 2, SO 2, O 3, and CO), heavy traffic, outdoor pesticides, and extreme temperatures. Additionally, the SR evaluated the impact of the efficacy of interventions reducing outdoor pollutants. The risk of bias was assessed using ROBINS‐E tools and the certainty of the evidence by using GRADE. Short‐term exposure to PM2.5, PM10, and NO 2 probably increases the risk of asthma‐related hospital admissions (HA) and emergency department (ED) visits (moderate certainty evidence). Exposure to heavy traffic may increase HA and deteriorate asthma control (low certainty evidence). Interventions reducing outdoor pollutants may reduce asthma exacerbations (low to very low certainty evidence). Exposure to fumigants may increase the risk of new‐onset asthma in agricultural workers, while exposure to 1,3‐dichloropropene may increase the risk of asthma‐related ED visits (low certainty evidence). Heatwaves and cold spells may increase the risk of asthma‐related ED visits and HA and asthma mortality (low certainty evidence).

          Related collections

          Most cited references116

          • Record: found
          • Abstract: found
          • Article: found
          Is Open Access

          ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions

          Non-randomised studies of the effects of interventions are critical to many areas of healthcare evaluation, but their results may be biased. It is therefore important to understand and appraise their strengths and weaknesses. We developed ROBINS-I (“Risk Of Bias In Non-randomised Studies - of Interventions”), a new tool for evaluating risk of bias in estimates of the comparative effectiveness (harm or benefit) of interventions from studies that did not use randomisation to allocate units (individuals or clusters of individuals) to comparison groups. The tool will be particularly useful to those undertaking systematic reviews that include non-randomised studies.
            Bookmark
            • Record: found
            • Abstract: not found
            • Article: not found

            Meta-analysis in clinical trials

              Bookmark
              • Record: found
              • Abstract: found
              • Article: found
              Is Open Access

              AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both

              The number of published systematic reviews of studies of healthcare interventions has increased rapidly and these are used extensively for clinical and policy decisions. Systematic reviews are subject to a range of biases and increasingly include non-randomised studies of interventions. It is important that users can distinguish high quality reviews. Many instruments have been designed to evaluate different aspects of reviews, but there are few comprehensive critical appraisal instruments. AMSTAR was developed to evaluate systematic reviews of randomised trials. In this paper, we report on the updating of AMSTAR and its adaptation to enable more detailed assessment of systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both. With moves to base more decisions on real world observational evidence we believe that AMSTAR 2 will assist decision makers in the identification of high quality systematic reviews, including those based on non-randomised studies of healthcare interventions.
                Bookmark

                Author and article information

                Contributors
                (View ORCID Profile)
                (View ORCID Profile)
                (View ORCID Profile)
                (View ORCID Profile)
                (View ORCID Profile)
                (View ORCID Profile)
                (View ORCID Profile)
                (View ORCID Profile)
                (View ORCID Profile)
                (View ORCID Profile)
                (View ORCID Profile)
                (View ORCID Profile)
                (View ORCID Profile)
                (View ORCID Profile)
                (View ORCID Profile)
                (View ORCID Profile)
                Journal
                Allergy
                Allergy
                Wiley
                0105-4538
                1398-9995
                July 2024
                February 04 2024
                July 2024
                : 79
                : 7
                : 1725-1760
                Affiliations
                [1 ] Faculty of Medicine Transylvania University Brasov Romania
                [2 ] Department of Clinical Epidemiology and Public Health, Iberoamerican Cochrane Centre Biomedical Research Institute Sant Pau (IIB Sant Pau) Barcelona Spain
                [3 ] Institute Desbrest of Epidemiology and Public Health, University of Montpellier and INSERM Montpellier France
                [4 ] Centre of Bioclimatology University of Florence Florence Italy
                [5 ] Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP) Madrid Spain
                [6 ] Allergy and Clinical Immunology Unit San Giovanni di Dio Hospital Florence Italy
                [7 ] Imperial College London UK
                [8 ] Medical School of Respiratory Diseases University of Naples Federico II Naples Italy
                [9 ] Department of Ecology, School of Biology, Faculty of Sciences Aristotle University of Thessaloniki Thessaloniki Greece
                [10 ] Department of Medical Sciences and Public Health University of Cagliari Monserrato Italy
                [11 ] Department of Allergy Hospital La Paz Institute for Health Research (IdiPAZ) Madrid Spain
                [12 ] Department of Botany, Ecology and Plant Physiology International Campus of Excellence on Agrifood (ceiA3), University of Córdoba Córdoba Spain
                [13 ] Environmental Medicine, Faculty of Medicine University of Augsburg Augsburg Germany
                [14 ] Allergy Unit Meyer Children's Hospital IRCCS Florence Italy
                [15 ] Department of Health Sciences University of Florence Florence Italy
                [16 ] Faculty of Medicine University of Southampton Southampton UK
                [17 ] Occupational Medicine Division and Centre for Environmental & Occupational Health Research University of Cape Town Rondebosch South Africa
                [18 ] John Rock Professor of Climate and Population Studies; Chair, Department of Environmental Health, Interim Director Center for Climate, Health, and The Global Environment, Harvard T.H. Chan School of Public Health Boston Massachusetts USA
                [19 ] Allergy and Clinical Immunology Unit, Second Pediatric Clinic National and Kapodistrian University of Athens Athens Greece
                [20 ] Division of Evolution and Genomic Sciences University of Manchester Manchester UK
                [21 ] Instituto Carlos III, Ministry of Science and Innovation, Allergy Service, Fundación Jiménez Díaz Faculty of Medicine Universidad Autónoma de Madrid and CIBERES Madrid Spain
                [22 ] Department of Environmental Medicine, Faculty of Medicine University of Augsburg Augsburg Germany
                [23 ] Institute of Environmental Medicine, Helmholtz Center Munich‐German Research Center for Environmental Health Augsburg Germany
                [24 ] Christine Kühne Center for Allergy Research and Education Davos Switzerland
                [25 ] Department of Occupational Diseases and Environmental Health Nofer Institute of Occupational Medicine Lodz Poland
                [26 ] MEDCIDS‐Department of Community Medicine, Information and Health Decision Sciences, Faculty of Medicine University of Porto Porto Portugal
                [27 ] Department of Clinical Immunology, ALL‐MED Medical Research Institute Wrocław Medical University Wroclaw Poland
                [28 ] Swiss Institute of Allergy and Asthma Research (SIAF), University Zurich Davos Switzerland
                Article
                10.1111/all.16041
                4c15e94d-b388-4377-a316-138679bbb735
                © 2024

                http://onlinelibrary.wiley.com/termsAndConditions#vor

                History

                Comments

                Comment on this article